Verve Therapeutics
VERV
#6794
Rank
NZ$0.86 B
Marketcap
$10.16
Share price
11.24%
Change (1 day)
-55.24%
Change (1 year)

Verve Therapeutics (VERV) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.95 Billion

According to Verve Therapeutics's latest financial reports the company has NZ$0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Verve Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.98 B12.91%
2022-12-31NZ$0.87 B65.6%
2021-12-31NZ$0.52 B428.01%
2020-12-31NZ$99.94 M258.37%
2019-12-31NZ$27.88 M